1. Home
  2. SYNA vs ADPT Comparison

SYNA vs ADPT Comparison

Compare SYNA & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synaptics Incorporated $0.001 Par Value

SYNA

Synaptics Incorporated $0.001 Par Value

HOLD

Current Price

$131.55

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$13.05

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYNA
ADPT
Founded
1986
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
2001
2019

Fundamental Metrics

Financial Performance
Metric
SYNA
ADPT
Price
$131.55
$13.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
9
Target Price
$100.78
$17.78
AVG Volume (30 Days)
890.8K
1.5M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
$663,588,000.00
$276,976,000.00
Revenue This Year
$12.63
$3.98
Revenue Next Year
$9.67
$22.72
P/E Ratio
N/A
N/A
Revenue Growth
21.04
54.77
52 Week Low
$57.54
$8.50
52 Week High
$129.78
$20.76

Technical Indicators

Market Signals
Indicator
SYNA
ADPT
Relative Strength Index (RSI) 77.95 41.50
Support Level $63.44 $12.22
Resistance Level N/A $13.45
Average True Range (ATR) 7.70 0.75
MACD 3.48 -0.09
Stochastic Oscillator 93.50 5.20

Price Performance

Historical Comparison
SYNA
ADPT

About SYNA Synaptics Incorporated $0.001 Par Value

Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: